Neutrophil-to-lymphocyte ratio predicts PSA response, but not outcomes in patients with castration-resistant prostate cancer treated with docetaxel


Sumbul A. T. , Sezer A., Abali H., Kose F., Gultepe I., Mertsoylu H., ...Daha Fazla

INTERNATIONAL UROLOGY AND NEPHROLOGY, cilt.46, sa.8, ss.1531-1535, 2014 (SCI İndekslerine Giren Dergi) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 46 Konu: 8
  • Basım Tarihi: 2014
  • Doi Numarası: 10.1007/s11255-014-0664-7
  • Dergi Adı: INTERNATIONAL UROLOGY AND NEPHROLOGY
  • Sayfa Sayıları: ss.1531-1535

Özet

The neutrophil-to-lymphocyte ratio (NLR) is a marker of systemic inflammatory response and evidences for the relationship between NLR and the response to treatment gradually increases in cancer patients. In this study, we aimed to investigate the effect of the pretreatment NLR and other factors related to the patient on predicting the outcome of docetaxel + prednisone chemotherapy in prostate cancer patients who become castration resistant.